/Investor DB

M Capital Partners — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

SmartCatchsmartcatch.frinMar 2017

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring.

BiotechDeep TechHealthtechMedical DevicesPortola Valley, US

MARK DAHM(Executive Officer, Director)

BoardRICHARD DEATLEY(Director)ROBERT TERRY(Director)TJ DURNAN(Director)

Co-investorsKurma Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.